.jpg?width=690&height=468&name=AI-ML-in-life-sciences%20(1).jpg)
Axtria, a global leader in cloud software and data analytics for the life sciences commercial business, is proud to announce the company has been ranked one of the Fast 100 Asian American Businesses in 2020 by the US Pan Asian American Chamber of Commerce Education Foundation (USPAACC).
Axtria was chosen because the company has demonstrated resilience and performance with excellence in managing, operating, and delivering on the company’s promise to its clients. Axtria, along with the other top 99 businesses, generated $2.6 billion in annual revenue and created thousands of jobs.
In announcing their decision, the USPAACC told Axtria’s CEO and President Jassi Chadha that “Axtria has demonstrated resilience and performance with excellence in managing, operating and delivering on your promise to your clients, and creating a healthy profit for your business.” Susan Au Allen, the USPAACC’s CEO and president added, “We know it is your hard work, dedication, and perseverance that drive success. The Pan Asian American community is grateful for your contributions to the vitality of the economy and quality of American life.”
Over the years, Axtria has worked with its clients to improve their sales and marketing effectiveness via data-driven decision making. The company is disrupting the life sciences commercial business by enabling new possibilities through the standardization of data to analytics to operations.
2020 marks the 13th year that USPAACC has celebrated the 100 fastest-growing Asian American businesses. Historically, the winners are honored at the USPAACC’s annual CelebrASIAN Business + Procurement Conference event. However, this year, the honorees are virtually being announced, with the potential of an award ceremony to be held in late October/early November.
“We are honored to be recognized by USPAACC as a Fast 100 Asian American Business,” said CEO and President Jassi Chadha. “We’ve worked hard over the past ten years to make Axtria one of the biggest global commercial solutions providers in the life sciences industry.”